Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Strongbridge Biopharma plc (SBBP)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
   10-K10-K10-K10-K10-K10-K20-F20-F
Net income  -45.1-60.815.5-113.5-49.2-43.6-9.7-5.3
Depreciation and amortization   [+]5.15.17.25.00.00.00.00.0
Asset impairment charges     20.716.40.6  
Stock-based compensation  7.48.67.85.24.63.90.30.7
Deferred taxes     2.0-2.9-0.5-0.5-0.1
Change in working capital   [+]-3.220.7-7.70.7-0.420.04.03.2
Other operating activities  -2.3-18.4-107.434.6-0.2-17.8-3.6-2.0
Cash from operations  -38.1-44.8-84.6-45.3-31.7-37.4-9.5-3.5
   
Capital expenditures  0.0-0.1-0.30.00.00.00.00.0
Sales of short-term investments, net   [+]21.1-20.7      
Other cash from investing    134.7-7.5-3.4-4.3  
Cash from investing  21.1-20.8134.3-7.5-3.4-4.30.00.0
   
Issuance of common stock, net  28.6 42.126.432.3  14.9
Option exercises   0.20.10.60.1   
Other cash from financing  18.90.3-26.817.818.177.410.2 
Cash from financing  47.50.115.243.550.377.410.214.9
   
Free cash flow  -38.1-44.9-84.9-45.3-31.7-37.4-9.5-3.5
        Per share (diluted)  ($0.66)($0.81)($1.71)($1.24)($1.46)($2.25)($1.18)($0.58)
   
Cash paid for interest  0.6 11.12.90.0   
Cash paid for income taxes  0.70.40.00.1    

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy